STAA
STAA
NASDAQ · Health Care

Staar Surgical Co

$32.07
+0.06 (+0.19%)
Financial Highlights (FY 2026)
Revenue
242.39M
Net Income
-81,438,676
Gross Margin
76.2%
Profit Margin
-33.6%
Rev Growth
-5.6%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 76.2% 76.2% 30.6% 30.6%
Operating Margin -38.3% -34.5% 8.4% 8.7%
Profit Margin -33.6% -31.9% 7.3% 8.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 242.39M 256.69M 486.07M 513.34M
Gross Profit 184.68M 195.57M 148.75M 157.10M
Operating Income -92,835,063 -88,479,886 40.82M 44.63M
Net Income -81,438,676 -77,618,138 35.57M 44.58M
Gross Margin 76.2% 76.2% 30.6% 30.6%
Operating Margin -38.3% -34.5% 8.4% 8.7%
Profit Margin -33.6% -31.9% 7.3% 8.7%
Rev Growth -5.6% -5.6% +17.3% +19.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 147.26M 115.78M
Total Equity 318.55M 341.72M
D/E Ratio 0.46 0.34
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -85,382,657 -85,898,045 66.49M 63.49M
Free Cash Flow 29.94M 30.72M